Atorvastatin / Fenofibrate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: (10mg + 160mg),(20mg + 145mg)
Reference Brands: Various Indian Brand Available
Category:
Heart Disorder
Atorvastatin+Fenofibrate is a combination of two lipids (fat) lowering medicines. It is used to lower the levels of lipids known as cholesterol and triglycerides in the blood when lifestyle changes (eg. low-fat diet) on their own have failed. This medicine helps to reduce the risk of heart disease.
Atorvastatin / Fenofibrate Tablets is available in Tablets
and strengths such as (10mg + 160mg),(20mg + 145mg).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Atorvastatin / Fenofibrate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Atorvastatin / Fenofibrate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Atorvastatin and fenofibrate are commonly used lipid-lowering medications that help manage dyslipidemia by targeting different aspects of abnormal lipid levels. Statins such as atorvastatin primarily work by inhibiting the enzyme responsible for cholesterol synthesis in the liver, which leads to a reduction in low-density lipoprotein (LDL) cholesterol and total cholesterol levels. Fenofibrate, on the other hand, belongs to the fibrate class of medications and mainly helps reduce triglyceride levels while increasing high-density lipoprotein (HDL) cholesterol.
In clinical practice, the coadministration of statin and fenofibrate monotherapies is frequently used for patients with mixed dyslipidemia who require more comprehensive lipid control. This combination therapy helps address multiple lipid abnormalities simultaneously, including elevated LDL cholesterol and high triglyceride levels. Such an approach is particularly beneficial for patients at increased risk of cardiovascular diseases.
Although the combination of these two agents is widely prescribed together in many treatment protocols, a fixed-dose combination tablet has not been widely marketed in certain regulated markets. Nevertheless, the dual therapy approach remains an important strategy in managing complex lipid disorders under proper medical supervision and regular lipid monitoring.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing